Plastic Surgery Hospital


Plastic Surgery Hospital (PSH) was founded in 1957 by a group led by Dr. Ruyao Song, a noted plastic surgeon. Being the cradle of Chinese plastic surgery, it was the first center to offer patient care, teaching, and research in the field. Currently the hospital has more than 700 employees, including 174 physicians.It performs more than 40,000 plastic and reconstructive surgeries, and sees nearly 140,000 outpatients, annually. The hospital has established more than 20 subspecialty centers, including centers for cleft lip and palate repair, auricular reconstruction, cranio maxillofacial surgery, burn surgery, breast surgery, hypospadias repair, rhinoplasty, hair transplantation, and laser surgery.

Clinical work at PSH focuses on developing innovative surgical techniques for repairing organ disorders and for the treatment of disease-related or trauma-related tissue damage. Hospital doctors have used pre-expanded skin flaps combined with autologous cartilage to reconstruct auricular defects in nearly 20,000 microtia patients. They have also developed new surgical techniques for treating cleft lip by proposing a concept of “group configuration” for muscle tension lines as the key to determine the nasolabial appearance, optimizing outcomes in nearly 10,000 cases. Other innovations include using scrotal septal neurovascular pedicle island skin flapsto repair hypospadias in a single step. Dr. Ruyao Song popularized the use of the forearm skin flap, later called the Chinese flap, for flap and reconstructive microsurgery. Since it was first reported by Dr. Yeguang Song at PSH in 1984, the anterolateral thigh flap has become one of the most widely used flaps in traumatic and oncological reconstruction.

With the recent growth of China’s economy, cosmetic surgery has become increasingly common. In the field of cosmetic maxillofacial surgery, gonioplasty, L-shaped zygomatic osteotomy, and the implantation of coral artificial bone into the separated mandibular cortex have been usedto reshape facial contours. In mammoplasty, a free-style endoscopic dissection technique was developed to perform transaxillary augmentation mammoplasty and has been used in over 1,000 cases.

PSH regularly conducts basic and clinical research relating to plastic surgery. Preliminary clinical studies are underway to explore using tissue-engineered bone to treat alveolar cleft and tissue-engineered cartilage to construct human auricular and nasal cartilage, providing alternative therapeutic strategies for orthopedic diseases in which bone and cartilage tissues are lacking. In the area of stem cells and tissue regeneration, PSH researchers have systematically investigated the biological characteristics of stem cells isolated at different developmental stages, and from different tissue sources and cellular microenvironments, and have explored the use of adipose tissue-derived mesenchymal stem cells in plastic surgery. They are currently investigating the coordinated behavior of skin-derived stem cells during skin development and regeneration. 

Patients with congenital disorders are commonly seen in PSH. The hospital has established biological specimen banks for these disorders and used “big data” analysis to make precise genotype-phenotype correlations for these diseases. Recently, clinical investigators at PSH used genome-wide association studies to identify a number of genetic loci related to craniofacial microsomia. Human embryonic stem cell-derived neural crest cells were also employed to study the molecular mechanisms behind congenital disorders induced by teratogenic factors including drugs and chemicals.

As one of the teaching hospitals of PUMC, PSH has educated over 600 postgraduate students in plastic surgery, anesthesiology, and cellular and molecular biology, and trained more than 3,000 plastic surgery fellows from around the world. In the last decade, the hospital has conducted 129 research projects, obtained 91 national patents, and published more than 500 peer-reviewed papers. The editorial office of the Chinese Journal of Plastic Surgery, a leading research journal in the field in China, is located in the hospital. Facing the challenges of plastic surgery in science and art, PSH are committed to explore the originative approach to improve the quality of the medical services.